. 2015 Mar 1;50(1):20–26. doi: 10.5152/tpa.2015.2281

Table 1.

Clinical, antropometric and laboratory properties of the subjects with CPP and PT

	CPP (n=51)	PT (n=36)	p
Age at presentation (years)	7.12±1.18	6.59±1.47	0.068^a
Age of onset of complaints (years)	6.46±1.17	6.21±1.65	0.402^a
Bilateral breast development (%)	31 (60%)	16 (44%)	0.191^a
Basal LH	0.94±1.10	0.18±0.43	<0.001^b
Basal FSH	3.33±1.78	1.56±0.81	<0.001^a
Basal LH/FSH ratio	0.28±0.31	0.16±0.43	0.001^b
Peak LH	13.54±12.26	2.07±1.15	<0.001^a
Peak FSH	14.46±5.15	11.51±5.71	0.041^a
Peak LH/FSH ratio	1.11±1.01	0.19±0.09	<0.001^b
BMI SDS	0.41±1.12	0.22±0.85	0.403^a
Height SDS	1.03±1.07	0.50±0.82	0.008^a
Bone age	8.81±1.97	7.11±1.63	<0.001^a
Bone age/chronological age (years)	1.24±0.25	1.05±0.19	<0.001^a
Target height SDS	−0.45±0.90	−0.62±0.69	0.374^b

Student T test;

Mann-Whitney U test

FSH: follicle stimulatin hormone; LH: luteinizing hormone; PT: premature telarche; CPP: central precocious puberty; SDS: Standard deviation score; BMI: body mass index